On one hand, some studies suggest that low-neuroendocrine SCLC (a group that includes SCLC-P) is an immune-’hot’ phenotype with high T-cell infiltration and PD-L1 expression, making it a promising candidate for immunotherapy [31,32]. The gene discussed is CD274; the disease is small cell lung carcinoma.